Business Description
Eurofins Scientific SE
ISIN : FR0014000MR3
Compare
Compare
Traded in other countries / regions
0MV5.UKERF.FranceERFSF.USAESF0.GermanyESF.AustriaERF.Switzerland IPO Date
1997-10-24Description
Eurofins, headquartered in Luxembourg, has three main business lines: food and environment testing, services to pharmaceutical and biotechnology companies, and clinical diagnostics. Through its subsidiaries, Eurofins provides various analytical testing and laboratory services on a global scale and offers testing options for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products. The company also has a growing clinical diagnostics unit with specialties in infectious diseases, prenatal screening, and organ transfer. Eurofins operates over 900 laboratories in 54 countries.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.66 | |||||
| Debt-to-EBITDA | 2.52 | |||||
| Interest Coverage | 5.94 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.59 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.3 | |||||
| 3-Year EBITDA Growth Rate | 17.4 | |||||
| 3-Year EPS without NRI Growth Rate | 43 | |||||
| 3-Year FCF Growth Rate | 7.9 | |||||
| 3-Year Book Growth Rate | 16.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 4.61 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.67 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.73 | |||||
| 9-Day RSI | 44.17 | |||||
| 14-Day RSI | 43.59 | |||||
| 6-1 Month Momentum % | -9.64 | |||||
| 12-1 Month Momentum % | -9.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.43 | |||||
| Quick Ratio | 1.35 | |||||
| Cash Ratio | 0.38 | |||||
| Days Inventory | 24.57 | |||||
| Days Sales Outstanding | 59.18 | |||||
| Days Payable | 104.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.81 | |||||
| Dividend Payout Ratio | 0.44 | |||||
| 3-Year Dividend Growth Rate | 51.4 | |||||
| Forward Dividend Yield % | 1.81 | |||||
| 5-Year Yield-on-Cost % | 1.81 | |||||
| 3-Year Average Share Buyback Ratio | -2.5 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.82 | |||||
| Operating Margin % | 8.45 | |||||
| Net Margin % | 6.94 | |||||
| ROE % | 9.36 | |||||
| ROA % | 4.42 | |||||
| ROIC % | 4.93 | |||||
| ROC (Joel Greenblatt) % | 31.57 | |||||
| ROCE % | 8 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.62 | |||||
| Forward PE Ratio | 19.34 | |||||
| PE Ratio without NRI | 24.62 | |||||
| Shiller PE Ratio | 34.19 | |||||
| Price-to-Owner-Earnings | 12.09 | |||||
| PEG Ratio | 1 | |||||
| PS Ratio | 1.71 | |||||
| PB Ratio | 2.16 | |||||
| Price-to-Free-Cash-Flow | 32.83 | |||||
| Price-to-Operating-Cash-Flow | 11.45 | |||||
| EV-to-EBIT | 19.7 | |||||
| EV-to-Forward-EBIT | 14.6 | |||||
| EV-to-EBITDA | 10.14 | |||||
| EV-to-Forward-EBITDA | 9.15 | |||||
| EV-to-Revenue | 2.02 | |||||
| EV-to-Forward-Revenue | 1.88 | |||||
| EV-to-FCF | 39.62 | |||||
| Price-to-Projected-FCF | 1.02 | |||||
| Price-to-DCF (Earnings Based) | 0.77 | |||||
| Price-to-DCF (FCF Based) | 1.03 | |||||
| Price-to-Median-PS-Value | 0.59 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.73 | |||||
| Earnings Yield (Greenblatt) % | 5.07 | |||||
| Forward Rate of Return (Yacktman) % | 24.63 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eurofins Scientific SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 6,510.1 | ||
| EPS (TTM) (€) | 2.28 | ||
| Beta | 0.3 | ||
| Volatility % | 21.41 | ||
| 14-Day RSI | 43.59 | ||
| 14-Day ATR (€) | 1.169169 | ||
| 20-Day SMA (€) | 55.423 | ||
| 12-1 Month Momentum % | -9.34 | ||
| 52-Week Range (€) | 52.78 - 72.64 | ||
| Shares Outstanding (Mil) | 192.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eurofins Scientific SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eurofins Scientific SE Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eurofins Scientific SE Frequently Asked Questions
What is Eurofins Scientific SE(XPAR:ERF)'s stock price today?
The current price of XPAR:ERF is €54.86. The 52 week high of XPAR:ERF is €72.64 and 52 week low is €52.78.
When is next earnings date of Eurofins Scientific SE(XPAR:ERF)?
The next earnings date of Eurofins Scientific SE(XPAR:ERF) is 2024-01-26 Est..
Does Eurofins Scientific SE(XPAR:ERF) pay dividends? If so, how much?
The Dividend Yield %  of Eurofins Scientific SE(XPAR:ERF) is 1.81% (As of Today), Highest Dividend Payout Ratio of Eurofins Scientific SE(XPAR:ERF) was 0.44. The lowest was 0.17. And the median was 0.24. The  Forward Dividend Yield % of Eurofins Scientific SE(XPAR:ERF) is 1.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers